These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1503413)

  • 21. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy.
    Otvos JD; Jeyarajah EJ; Bennett DW
    Clin Chem; 1991 Mar; 37(3):377-86. PubMed ID: 2004444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigations concerning the potential for using 1H NMR relaxometry or high-resolution spectroscopy of plasma as a screening test for malignant lung disease.
    Schuhmacher JH; Conrad D; Manke HG; Clorius JH; Matys ER; Hauser H; Zuna I; Maier-Borst W; Hull WE
    Magn Reson Med; 1990 Jan; 13(1):103-32. PubMed ID: 2319928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between the proton nuclear magnetic resonance properties of plasma lipoproteins and cancer.
    Otvos JD; Jeyarajah EJ; Hayes LW; Freedman DS; Janjan NA; Anderson T
    Clin Chem; 1991 Mar; 37(3):369-76. PubMed ID: 2004443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some factors that influence the plasma lipoprotein 1H NMR spectra of normal and cancer patients: an oncolipid test?
    Lim HM; Price TB; Marsh JC; Rainey PM; Gore JC; Armitage IM
    Yale J Biol Med; 1991; 64(1):63-77. PubMed ID: 1897263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time and frequency domain analysis of NMR data compared: an application to 1D 1H spectra of lipoproteins.
    van den Boogaart A; Ala-Korpela M; Jokisaari J; Griffiths JR
    Magn Reson Med; 1994 Apr; 31(4):347-58. PubMed ID: 8208109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tumor detection in serum by NMR spectrometry. A critical evaluation of the so-called Fossel test].
    Schalk KP; Rüterjans H; Kaltwasser JP; Said l-Hadj H; Staffenberger L
    Onkologie; 1989 Aug; 12 Suppl 1():5-8. PubMed ID: 2685697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of tumours with nuclear magnetic resonance spectroscopy of plasma.
    Berger S; Pflüger KH; Etzel WA; Fischer J
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):535-43. PubMed ID: 2703007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton nuclear magnetic resonance spectroscopy of serum lipoproteins in rabbits with implanted VX-2 carcinoma.
    Gadeholt G; Kruse S; Halsteinslid L; Sletten E
    Eur J Cancer; 1990; 26(5):611-5. PubMed ID: 2144751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride.
    May GL; Wright LC; Holmes KT; Williams PG; Smith IC; Wright PE; Fox RM; Mountford CE
    J Biol Chem; 1986 Mar; 261(7):3048-53. PubMed ID: 3949759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of aliphatic lipid proton NMR linewidths by malignant tumors in guinea pigs.
    Fossel ET; Dvorak HF; Carr JM; McDonagh J
    Eur J Cancer; 1990 Jan; 26(1):29-32. PubMed ID: 2138474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics.
    Ala-Korpela M
    Clin Chem Lab Med; 2008; 46(1):27-42. PubMed ID: 18020967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR spectroscopy evaluation of plasma "oncolipids" in head and neck cancer.
    Scher RL; Ropka ME; Neal DA; Berr S; Trouard T; Deutsch B; Cantrell RW; Levine PA
    Otolaryngol Head Neck Surg; 1990 Jan; 102(1):34-40. PubMed ID: 2106116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy.
    Wilding P; Senior MB; Inubushi T; Ludwick ML
    Clin Chem; 1988 Mar; 34(3):505-11. PubMed ID: 3349601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of 1H nuclear magnetic resonance spectroscopy of blood plasma to detect malignancy.
    Okunieff P; Greenberg MD; Zietman A; Kahn J; Westgate S; Neuringer LJ
    J Clin Oncol; 1990 May; 8(5):906-10. PubMed ID: 2332773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoproteins in heart transplantation: proton magnetic resonance spectroscopy of plasma.
    Eugene M; Le Moyec L; de Certaines J; Desruennes M; Le Rumeur E; Fraysse JB; Cabrol C
    Magn Reson Med; 1991 Mar; 18(1):93-101. PubMed ID: 2062246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
    Dowd TL; Kaplan BA; Gupta RK; Aisen P
    Magn Reson Med; 1987 Oct; 5(4):395-7. PubMed ID: 3683172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-resolution NMR spectra of high-density serum lipoproteins.
    Chapman D; Leslie RB; Hirz R; Scanu AM
    Biochim Biophys Acta; 1969 Apr; 176(3):524-36. PubMed ID: 5800042
    [No Abstract]   [Full Text] [Related]  

  • 38. 1H NMR studies on human plasma lipids from newborn infants, healthy adults, and adults with tumors.
    Eskelinen S; Hiltunen Y; Jokisaari J; Virtanen S; Kiviniitty K
    Magn Reson Med; 1989 Jan; 9(1):35-8. PubMed ID: 2540395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and biophysical alterations of lipoprotein after liver transplantation from a living related donor. A biochemical and proton NMR study.
    Iwata S; Tanaka A; Inubushi T; Sano K; Uemoto S; Kitai T; Yamaoka Y; Tanaka K; Ozawa K
    Res Exp Med (Berl); 1994; 194(5):313-20. PubMed ID: 7855447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting 1H NMR spectra of blood plasma: cancer, diet and freezing.
    Bell JD; Brown JC; Norman RE; Sadler PJ; Newell DR
    NMR Biomed; 1988 Apr; 1(2):90-4. PubMed ID: 2484277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.